knowledge -WSS

knowledge

author：hotspot 2025-09-06 09:56:35 Page View：2

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approves first blood sugar monitor without finger pricks
Next article： Sports medicine is finally prioritizing gender equality

Wikipedia

Bright Health sells Medicare Advantage business to Molina

BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

FDA approves first blood sugar monitor without finger pricks

TheFDAhasapprovedadevicefromAbbottthatcontinuouslymonitorsdiabetics’bloodsugarlevelswithoutrequiring

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

Severe heat forecast: Where scorching temperatures will persist over the next week

4:01Amanwalksalongasidewalkunderthemisters,July14,2023,indowntownPhoenix.MattYork/APAnunrelentinghea

knowledge

focus

Wikipedia

Severe heat forecast: Where scorching temperatures will persist over the next week